IMMUNOASSAY INSTRUMENTS MARKET ANALYSIS

Regional Analysis

Asia Pacific is expected to lead the market promoting the utilization of immunoassays with the rise in infectious diseases

Regional segmentation of the immunoassay instruments market by Coherent Market Insights comprises North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. North America is expected to dominate the global market owing to the rising demand for technologically advanced clinical diagnostic analyzers capable to perform multiple immunoassays simultaneously. According to the article published in Genetic Engineering and Biotechnology News (GEN), the market for infectious disease testing in the U.S. is expected to grow from U.S. $168 billion in 2015 to U.S. $209 billion in 2020 owing to the upsurge of infectious diseases. Additionally, the rising grants from the government and the private healthcare agencies, contributing towards the development of technology and commercialization of immunoassay analyzers, thereby raising the market in North America. The immunoassay instruments market is expected to boost in Asia Pacific owing to the rising research activities in microbiology sector, increasing the prevalence of infectious and chronic diseases like cholera, tuberculosis, typhoid, autoimmune diseases and rising government healthcare grants. For instance, China directed immunoassay market at an estimated U.S. $626 million in 2013 and is estimated to reach U.S. $1309 million by 2018.